Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Yu-waye Chu currently holds 189,446 shares of FATE THERAPEUTICS INC (FATE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yu-waye Chu has been a net seller of FATE stock. They have purchased $0 and sold $1.2M worth of shares.
Yu-waye Chu's most recent insider trade was on Mar 17, 2026, when they sold 21,279 shares at $6.42 per share.
Yu-waye Chu serves as Executive at FATE THERAPEUTICS INC (FATE). They have executed 25 insider transactions totaling $1.2M over their tenure at the company.
Yu-waye Chu holds the position of Executive at FATE THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Yu-waye Chu has shown a selling trading pattern, with $0 in total purchases and $1.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Yu-waye Chu was on Jan 11, 2022, when they sold $171.8K worth of FATE shares. This transaction involved 3,547 shares at $48.44 per share.
Yu-waye Chu currently owns 189,446 shares of FATE THERAPEUTICS INC (FATE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Yu-waye Chu's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Yu-waye Chu has 25 Form 4 filings on record as an insider at FATE THERAPEUTICS INC.
Set alerts for Yu-waye Chu and 40,000+ other insiders.